Overview IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease Status: COMPLETED Trial end date: 2024-10-15 Target enrollment: Participant gender: Summary Double-masked, dose-response, trial of IVW-1001 in subjects with dry eye disease.Phase: PHASE1 Details Lead Sponsor: IVIEW Therapeutics Inc.